Interdigitating dendritic cell sarcoma of the parotid gland: case report and literature review

Guy Efune1, Baran D Sumer, Venetia R Sarode

  • 1Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390-9035, USA.

Insights

Interdigitating dendritic cell sarcoma (IDCS) is a rare cancer of immune cells. This case highlights a challenging IDCS diagnosis in the parotid gland, emphasizing diagnostic markers.

Area of Science:

  • Oncology
  • Immunology
  • Pathology

Background:

  • Interdigitating dendritic cell sarcoma (IDCS) is an exceptionally rare neoplasm originating from immune system's antigen-presenting cells.
  • Diagnosis of IDCS can be challenging due to its rarity and potential to mimic other tumors.

Observation:

  • A 69-year-old male presented with a parotid gland mass initially diagnosed as undifferentiated neoplasm.
  • Microscopic examination revealed atypical spindle cells in the parotid gland and a lymph node.
  • Immunophenotypic analysis showed positivity for S100, fascin, vimentin, and HLA-II, with negative markers for other cell types.

Findings:

  • The features were consistent with Interdigitating dendritic cell sarcoma (IDCS) of the parotid gland.
  • This represents one of only three reported cases of IDCS in the parotid gland.
  • Morphological similarity to other sarcomas posed a diagnostic challenge.

Implications:

  • Increased awareness of IDCS in unusual locations like the parotid gland is crucial for accurate diagnosis.
  • Utilizing specific immunophenotypic markers is essential for differentiating IDCS from other neoplasms.
  • Prompt diagnosis and appropriate treatment, including surgery and irradiation, are vital for patient outcomes.

Related Concept Videos